Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Allignol

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Vaccine|May 9, 2012
A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancyMarc Oppermann, Juliane Fritzsche, Corinna Weber-Schoendorfer, et al.
Journal of Clinical Psychopharmacology|June 15, 2013
Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort studyFrank Habermann, Juliane Fritzsche, Frederike Fuhlbrück, et al.
Gynecologic and Obstetric Investigation|June 27, 2023
Dosing Characteristics of Recombinant Human Luteinizing Hormone or Human Menopausal Gonadotrophin-Derived LH Activity in Patients Undergoing Ovarian Stimulation: A German Fertility Database StudyValerie Strezsak, Arthur Allignol, Klaus Bühler, et al.
Reproductive Biology and Endocrinology : RB&E|June 17, 2021
Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in GermanyKlaus F Bühler, Robert Fischer, Patrice Verpillat, et al.
Stroke|July 19, 2014
Neurovascular coupling in pregnancy and the risk of preeclampsiaWibke G Janzarik, Renata Ehmann, Elena Ehlers, et al.
American Journal of Medical Genetics. Part A|February 10, 2012
Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information ServicesMaria Hoeltzenbein, Elisabeth Elefant, Thierry Vial, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|March 19, 2022
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registryKlaus Bühler, Claudia Roeder, Juan-Enrique Schwarze, et al.
Frontiers in Oncology|October 30, 2025
European experience of patients with HER2-positive advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: the EUROPA T-DXd studyCristina Saura, Hans Wildiers, Giampaolo Bianchini, et al.
Cancer Medicine|October 20, 2022
Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatmentDavid P Cosgrove, Emily S Reese, Nicole M Fulcher, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 25, 2015
Endovascular Treatment versus Sonothrombolysis for Acute Ischemic StrokeMatthias Reinhard, Christian A Taschner, Nicole Hörsch, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Vaccine|May 9, 2012
A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancyMarc Oppermann, Juliane Fritzsche, Corinna Weber-Schoendorfer, et al.
Journal of Clinical Psychopharmacology|June 15, 2013
Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort studyFrank Habermann, Juliane Fritzsche, Frederike Fuhlbrück, et al.
Gynecologic and Obstetric Investigation|June 27, 2023
Dosing Characteristics of Recombinant Human Luteinizing Hormone or Human Menopausal Gonadotrophin-Derived LH Activity in Patients Undergoing Ovarian Stimulation: A German Fertility Database StudyValerie Strezsak, Arthur Allignol, Klaus Bühler, et al.
Reproductive Biology and Endocrinology : RB&E|June 17, 2021
Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in GermanyKlaus F Bühler, Robert Fischer, Patrice Verpillat, et al.
Stroke|July 19, 2014
Neurovascular coupling in pregnancy and the risk of preeclampsiaWibke G Janzarik, Renata Ehmann, Elena Ehlers, et al.
American Journal of Medical Genetics. Part A|February 10, 2012
Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information ServicesMaria Hoeltzenbein, Elisabeth Elefant, Thierry Vial, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|March 19, 2022
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registryKlaus Bühler, Claudia Roeder, Juan-Enrique Schwarze, et al.
Frontiers in Oncology|October 30, 2025
European experience of patients with HER2-positive advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: the EUROPA T-DXd studyCristina Saura, Hans Wildiers, Giampaolo Bianchini, et al.
Cancer Medicine|October 20, 2022
Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatmentDavid P Cosgrove, Emily S Reese, Nicole M Fulcher, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 25, 2015
Endovascular Treatment versus Sonothrombolysis for Acute Ischemic StrokeMatthias Reinhard, Christian A Taschner, Nicole Hörsch, et al.
Pageof 5